Charles Schwab Investment Management Inc Aurinia Pharmaceuticals Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 511,731 shares of AUPH stock, worth $6.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

511,731

Previous 521,416 1.86%

Holding current value

$6.06 Million

Previous $4.19 Million 3.39%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$7.2 - $8.64 $69,732 - $83,678	-9,685 Reduced 1.86%	511,731 $4.33 Million
Q1 2025 Sep 15, 2025	BUY	$7.55 - $8.77 $73,121 - $84,937	9,685 Added 1.89%	521,416 $4.19 Million
Q1 2025 May 09, 2025	SELL	$7.55 - $8.77 $1.08 Million - $1.26 Million	-143,671 Reduced 21.6%	521,416 $4.19 Million
Q4 2024 Feb 06, 2025	SELL	$6.75 - $10.44 $533,000 - $824,373	-78,963 Reduced 10.61%	665,087 $5.97 Million
Q3 2024 Nov 12, 2024	BUY	$5.32 - $7.33 $478,480 - $659,260	89,940 Added 13.75%	744,050 $5.45 Million
Q2 2024 Aug 12, 2024	BUY	$4.81 - $5.78 $553,881 - $665,578	115,152 Added 21.37%	654,110 $3.73 Million
Q1 2024 May 08, 2024	BUY	$4.93 - $9.31 $496,781 - $938,140	100,767 Added 23.0%	538,958 $2.7 Million
Q4 2023 Feb 06, 2024	BUY	$7.13 - $9.49 $377,112 - $501,935	52,891 Added 13.73%	438,191 $3.94 Million
Q3 2023 Nov 08, 2023	BUY	$7.77 - $12.27 $573,006 - $904,863	73,746 Added 23.67%	385,300 $2.99 Million
Q2 2023 Aug 09, 2023	BUY	$8.96 - $11.69 $49,907 - $65,113	5,570 Added 1.82%	311,554 $3.02 Million
Q1 2023 May 11, 2023	BUY	$5.94 - $11.27 $31,297 - $59,381	5,269 Added 1.75%	305,984 $3.35 Million
Q4 2022 Feb 13, 2023	BUY	$4.11 - $8.14 $18,141 - $35,929	4,414 Added 1.49%	300,715 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $666 - $1,239	100 Added 0.03%	296,301 $2.23 Million
Q2 2022 Aug 15, 2022	BUY	$8.95 - $12.8 $2.65 Million - $3.79 Million	296,201 New	296,201 $2.98 Million

Others Institutions Holding AUPH

# of Institutions

248

Shares Held

62.5M

Call Options Held

1.03M

Put Options Held

666K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.68B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Aurinia Pharmaceuticals Inc. Transaction History